CClinicalTrials.gg
Active, not recruitingNCT06134713Updated Nov 18, 2023

Effect of Intra-Canal Cryotherapy on Postoperative Pain After Endodontic Procedures

A Phase 4 interventional study of cryotherapy with sterile saline at 2.5ºC and control with sterile saline at room temperature in Endodontically Treated Teeth and Post Operative Pain, sponsored by Ajman University. Active, not recruiting at 1 site in United Arab Emirates. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-18.

Sponsored by Ajman University · Phase 4, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Feb 2024, 2 years 7 months ago, but the record still lists the study as active, not recruiting.
  • Registered 5 months after the study started (first participant enrolled May 2023, registered Nov 2023).
Phase
Phase 4
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this randomised clinical trial is to evaluate the effect of cryotherapy on postoperative pain after primary and secondary root canal treatment. The main question[s] it aims to answer are:

  • Dose cryotherapy help reduce postoperative pain after primary root canal treatment.
  • Dose cryotherapy help reduce postoperative pain after secondary root canal treatment.

Participants will be randomly divided to receive either cryotherapy or irrigation with normal saline and the effect between the two groups in terms of postoperative pain will be compared after primary and secondary root canal treatment.

Read the detailed description

Procedure

Previous pain assessment:

Both pre- and postoperative pain will be assessed using Huskinsson's visual analog scale (VAS). According to the quantitative data obtained from the VAS scale, these values are categorized as follows: no pain (0), slight pain (0.1-3.9), moderate pain (4-6.9) or pain severe (7-10).

Informed consent After the procedure is carefully explained to the patient and the patient has accepted the treatment plan and signed the Consent, they will be included in the study. Students will give a complete explanation of the study, the forms of pain and how to properly fill out the pain form. If the patient wishes to participate, they will sign the document in order to continue with the treatment and be included in the study.

Root canal treatment and retreatment Vitality test which includes cold test using Endo Ice (Coltene, Switzerland) and Electrical pulp test (EPT) (Shadental, India) for cases of primary root canal treatment. Vertical and lateral percussion tests, periodontal probing, and periapical and bitewing radiographs will be performed in order to perform the pulpal and periapical diagnosis.

The general treatment protocol will be the same for all groups. In case of primary root canal treatment, after the clinical examination, the cold test (Endo-Frost, Coltene-Whaledent, Langenau, Germany) will be used to determine the vitality of the pulp, which will be verified by the presence or absence of bleeding from the root canals during the preparation of the pulp endodontic access.

Local infiltration with 2% lidocaine with epinephrine 1: 80,000 (Ultracain, Normon) will be performed, and absolute isolation with a rubber dam and the department's endodontic protocol will be followed. Access cavity with sterile round diamond drills and Endo-Z drills (Dentsply Maillefer, Ballaigues, Switzerland). The working length (WL) is established with a #10 K-file and apex locator and confirmed with a periapical radiograph. In case of secondary root canal treatment, gutta percha removal and disobturation will be done using different types of rotary and manual files and canals will be negotiated till patency is achieved in all canals, if patency is not achieved the case will be excluded from the study. After which for both primary and secondary root canal treatment instrumentation of the canals will be performed in which they will be irrigated with 1.3% NaOCl solution using a plastic syringe and side-exit needle (Max-i-probe, Kerr-Hawe, Bioggio, Switzerland). Apical patency will be maintained throughout the procedure. Once the procedure is complete, 1 ml of 17% EDTA will be used and a final irrigation with 1.3% NaOCl will be performed with ultrasonic activation using the Irrisafe tip (Acteon, UK).

In the control group, a final irrigation will be performed with 5 ml of 0.9% physiological saline (Sodium Chloride IV infusion 0.9% (Gulf Inject LLC)) at room temperature and in the experimental group with the saline at 2.5ºC for 4 minutes with an endo needle inserted at working length. The saline solution for the control group will be kept at room temperature. The saline solution of the experimental groups will be kept in a refrigerator set at 2.5 C until clinical use.

  • Group 1: Conventional root canal treatment with final irrigation with saline at room temperature (n=30).
  • Group 2: Conventional root canal retreatment with final irrigation with saline at room temperature (n=30).
  • Group 3: Conventional root canal treatment with final irrigation with saline at 2.5ºC for 4 minutes (n=30).
  • Group 2: Conventional root canal retreatment with final irrigation with saline at 2.5ºC for 4 minutes (n=30).

The canals will be dried with paper points. The canals of both groups will be filled using a warm gutta-percha filling technique. AH-Plus cement (Dentsply, DeTrey GmbH, Konstanz, Germany) will be used as root canal sealer. Each coronal access will be sealed with a flowable resin (Tetric, IvoclarVivadent AG, SchaanFurstentum, Liechtenstein) and the access cavity will be filled with Glass Ionomer Cement (GIC, ESPE dental, Seefeld, Germany).

Post-operative pain assessment A sheet will be given to the patient with different lines of VAS so that the patient reports the intensity of pain or its absence in the same way that he has been previously taught with preoperative pain at 8, 24 and 48h, 7 days. An ibuprofen 600 mg every 8-12 hours will be recommended for pain control when necessary. The type of analgesic, its quantity and dose will also be recorded in the event that the patients take any type of medication. Patients will be asked to return the VAS collection sheet at the next restoration or general treatment plan continuation visit at the University Clinic. Both the preoperative and postoperative pain results recorded on the Huskinsson VAS scale will be measured by an operator independent of the study, who will be previously calibrated, teaching the evaluator to measure 10 times with a ruler the distance between the initial point of the line to the point marked by the patient on it.

02

Conditions studied

  • Endodontically Treated Teeth
  • Post Operative Pain

Keywords

  • Root Canal Treatment
  • Post Operative Pain
  • Cryotherapy
  • Nonsurgical Root Canal Retreatment
03

In context

Tooth, Nonvital

113 studies on the registry are indexed under Tooth, Nonvital; 19 are open to participants now.

This study's planned enrollment of 120 is above the median of 50 across 103 interventional studies indexed under Tooth, Nonvital.

Browse Tooth, Nonvital studies →

Lead sponsor

Ajman University is the lead sponsor of 18 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients older than 18 years.
  • Patients who demonstrate understanding of the study and willingness to participate as evidenced by signing the voluntary informed consent and who received a signed and dated copy of the informed consent form.
  • Patients who understand and are willing to comply with all study procedures and restrictions.
  • Absence of clinically significant and relevant abnormalities in the clinical history or oral examination.
  • Endodontic treatment considered the treatment of choice for both multi and single rooted teeth.
  • Endodontic retreatment considered the treatment of choice only in posterior molar teeth (multirooted).
  • Only one treatment per patient.

Exclusion criteria

Exclusion Criteria:

  • Patients who are allergic to any of the materials used in the treatment.
  • Patients with heart pacemaker.
  • Patients with any general pathology that requires antibiotic prophylaxis.
  • Root resorption, root fractures, impossibility of restoration.
  • Pregnant patients.
  • Patients who took painkillers in the last 6 hours.
  • Case where apical patency couldn't be achieved
  • Cases where final obturation quality is compromised.
  • Any intra operative factor that complication that can compromise the treatment outcome like root perforation or fractured instrument or inability to localize/prepare any canal.
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Root canal treatment cryotherapy group

    Conventional root canal treatment with final irrigation using sterile saline at 2.5ºC

    Drug: cryotherapy with sterile saline at 2.5ºC

  • Experimental
    Root canal RE-treatment cryotherapy group

    Conventional root canal RE-treatment with final irrigation using sterile saline at 2.5ºC

    Drug: cryotherapy with sterile saline at 2.5ºC

  • Active comparator
    Root canal treatment control group

    Conventional root canal treatment with final irrigation using sterile saline at room temperature

    Drug: control with sterile saline at room temperature

  • Active comparator
    Root canal RE-treatment control group

    Conventional root canal RE-treatment with final irrigation using sterile saline at room temperature

    Drug: control with sterile saline at room temperature

Interventions

  • Drugcryotherapy with sterile saline at 2.5ºC

    In the cryotherapy (experimental group), final irrigation will be performed with 5 ml of 0.9% physiological sterile saline kept refrigerated at 2.5ºC and will be delivered for 1 or 4 minutes with a side vented needle inserted at working length for each canal.

  • Drugcontrol with sterile saline at room temperature

    In the control group, final irrigation will be performed with 5 ml of 0.9% physiological sterile saline kept at room temperature and will be delivered for 1 or 4 minutes with a side vented needle inserted at working length for each canal.

06

What researchers measure

Primary outcomes

  1. Postoperative pain assessment using the visual analog scale (VAS)

    Both pre- and postoperative pain will be assessed using the visual analog scale (VAS). According to the quantitative data obtained from the VAS scale (from 1 to 10), these values will be categorized as follows: no pain (0), slight pain (0.1-3.9), moderate pain (4-6.9) or severe pain (7-10)

    Time frame: Preoperative, 6 hours,12 hours, 24 hours, 48 hours, 72 hours, 5 days and 7 days

07

Study locations

1 site
  • Ajman University
    Ajman, United Arab Emirates
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06134713
Lead sponsor
Ajman University
Collaborators
Universitat Internacional de Catalunya
Responsible party
Firas Elmsmari (Principal Investigator, Ajman University) — Principal investigator
First posted
Nov 18, 2023
Start date
May 15, 2023
Primary completion
Feb 28, 2024 (estimated)
Completion
May 30, 2024 (estimated)
Last update
Nov 18, 2023

Study contacts

Firas H Elmsmari, PhD
principal investigator · Ajman University - College of Dentistry

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion